Single nucleotide polymorphisms of the fibroblast growth factor receptor 2 gene in patients with chronic venous insufficiency with leg ulcer [8]

Journal of Investigative Dermatology

Volumn 124, Issue 5, 2005, Pages 1085-1088

  Nagy, N ^a   Szolnoky, Gy ^a   Szabad, G ^a   Bata Csorgo Zs ^a   Dobozy, A ^a   Kemeny L ^a   Szell M ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR RECEPTOR; MESSENGER RNA;

3' UNTRANSLATED REGION; ADULT; AGED; CHRONIC VEIN INSUFFICIENCY; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; LEG ULCER; LETTER; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR GENE; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; WOUND HEALING;

EID: 18244393168     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23689.x     Document Type: Letter

References (15)

1. Auguste P, Gursel DB, Lemiere S, et al: Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and-independent mechanisms. Cancer Res 61:1717-1726, 2001
2. Baraniak AP, Lasda EL, Wagner EJ, Garcia-Blanco MA: A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements. Mol Cell Biol 23:9327-9337, 2003
3. Bauters C, Six I, Meurice T, Van Belle E: Growth factors and endothelial dysfunction. Drugs 59:11-15, 1999
4. Di Paola R, Frittitta L, Miscio G, et al: A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70:806-812, 2002
5. Kan SH, Elanko N, Johnson D, et al: Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet 70:472-486, 2002
6. Loot MA, Kenter SB, Au FL, van Galen WJ, Middelkoop E, Bos JD, Mekkes JR: Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol 81:153-160, 2002
7. Maas-Szabowski N, Szabowski A, Stark HJ, et al: Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation. J Invest Dermatol 116:816-820, 2001
8. McIntosh I, Bellus GA, Jab EW: The pleiotropic effects of fibroblast growth factor receptors in mammalian development. Cell Struct Funct 25:85-96, 2000
9. Munkvad S, Jorgensen M: Resistance to activated protein C: A common anti-coagulant deficiency in patients with venous leg ulceration. J Dermatol 134:295-298, 1996
10. Oldridge M, Zackai EH, McDonald-McGinn DM, et al: De novo Alu-element insertions in FGFR-2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet 64:471-711, 1999
11. Raccah D, Coste TC, Vague P: Genetics of diabetic complications: Peripheral neuropathy. Ann Endocrinol 65 (Suppl. 1):S5-S9, 2004
12. Shan S, Robson ND, Cao Y, et al: Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. FASEB J 18:326-328, 2004
13. Stucker M, Harke K, Rudolph T, Altmeyer P: Pathogenesis of therapy refractory ulcus cruris. Hautarzt 54:750-755, 2003
14. Vasilopoulos Y, Cork MJ, Murphy R, et al: Genetic association between an AACC insertion in the 3′UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 123:62-66, 2004
15. Yeh BK, Igarashi M, Eliseenkova AV, et al: Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc Natl Acad Sci USA 100:2266-2271, 2003